patient>

Indications and Usage:  
Cardiolite®, Kit for the Preparation of Technetium Tc99m Sestamibi for Injection, is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. Cardiolite® evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (eg, exercise or pharmacologic stress in accordance with the pharmacologic stress agent's labeling).

It is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia.

Important Safety Information:
Cardiolite® and Miraluma® are different names for the same drug. Inform your health care provider if you have had an allergic reaction to either drug or if you have had an imaging study with either drug.

Exercise and pharmacologic stress testing should be performed only under the supervision of a qualified doctor. On rare occasions, a very small number of people who are given Cardiolite® have serious allergic side effects, including skin rashes.  The most common complaints include headache, chest pain, nausea, and abnormal taste and smell.  There may also be some side effects that only the doctor will notice while your heart is being monitored.

If you are pregnant, suspect you may be pregnant, or are a nursing mother, discuss this with your doctor before undergoing the procedure.

If your doctor has decided to use a special drug to cause stress, instead of exercise activity, be sure to discuss your diet and other medicines prior to receiving the drug.  It is important that your doctor know all medicines that you are taking.  This includes any prescription medicines, over-the-counter drugs, or dietary supplements.

Please See Full Prescribing Information